JW Pharmaceutical   Report issue

Founded: Seoul Korea, Republic of (1945)

Organization Overview

First Clinical Trial
2008
NCT00663884
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

+82-2-840-6982 | JW Pharmaceutical | JWPharmaceuticals